➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Moodys
Colorcon
Baxter

Last Updated: October 17, 2021

DrugPatentWatch Database Preview

Isosorbide dinitrate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for isosorbide dinitrate and what is the scope of patent protection?

Isosorbide dinitrate is the generic ingredient in four branded drugs marketed by Auxilium Pharms Llc, Wyeth Ayerst, Astrazeneca, Impax Labs Inc, Sun Pharm Inds Inc, Bausch, Ani Pharms, Hikma Intl Pharms, Par Pharm, Sandoz, Sun Pharm Industries, Superpharm, Watson Labs, Zydus, Biovail, and Watson Labs Teva, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-seven drug master file entries for isosorbide dinitrate. Twenty suppliers are listed for this compound.

Drug Prices for isosorbide dinitrate

See drug prices for isosorbide dinitrate

Recent Clinical Trials for isosorbide dinitrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Pr. Semir NouiraPhase 3
Children's Hospital Medical Center, CincinnatiPhase 2
Danish Council for Independent ResearchPhase 4

See all isosorbide dinitrate clinical trials

Pharmacology for isosorbide dinitrate
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for isosorbide dinitrate

US Patents and Regulatory Information for isosorbide dinitrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 086032-001 Jan 7, 1988 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Astrazeneca SORBITRATE isosorbide dinitrate TABLET, CHEWABLE;ORAL 016776-002 Apr 1, 1996 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Par Pharm ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 086925-001 Mar 12, 1987 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Biovail ISORDIL isosorbide dinitrate TABLET;SUBLINGUAL 012940-004 Jul 29, 1988 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Astrazeneca SORBITRATE isosorbide dinitrate TABLET;ORAL 088124-001 Aug 21, 1990 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sun Pharm Industries ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;SUBLINGUAL 087545-001 Sep 18, 1986 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
AstraZeneca
Moodys
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.